These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 8617181

  • 21. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
    Appleton R, Fichtner K, LaMoreaux L, Alexander J, Halsall G, Murray G, Garofalo E.
    Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
    [Abstract] [Full Text] [Related]

  • 22. Clinical efficacy and safety of gabapentin.
    Ramsay RE.
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [Abstract] [Full Text] [Related]

  • 23. Gabapentin in refractory partial epilepsy--a trial in India.
    Dixit SN, Jain S, Padma MV, Maheshwari MC.
    Acta Neurol Scand; 1996 Jun; 93(2-3):85-7. PubMed ID: 8741123
    [Abstract] [Full Text] [Related]

  • 24. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A.
    Epilepsia; 1999 Jun; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [Abstract] [Full Text] [Related]

  • 25. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
    Brodie MJ, Chadwick DW, Anhut H, Otte A, Messmer SL, Maton S, Sauermann W, Murray G, Garofalo EA, Gabapentin Study Group 945-212.
    Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
    [Abstract] [Full Text] [Related]

  • 26. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A, Fakhoury T, Nasreddine W, Abou-Khalil B.
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [Abstract] [Full Text] [Related]

  • 27. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
    Handforth A, Treiman DM.
    Epilepsia; 1994 Feb; 35(5):1032-7. PubMed ID: 7925148
    [Abstract] [Full Text] [Related]

  • 28. [Safety and tolerability of gabapentin].
    Viteri C.
    Rev Neurol; 1994 Feb; 34(3):292-5. PubMed ID: 12022084
    [Abstract] [Full Text] [Related]

  • 29. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89.
    Bergey GK, Morris HH, Rosenfeld W, Blume WT, Penovich PE, Morrell MJ, Leiderman DB, Crockatt JG, LaMoreaux L, Garofalo E, Pierce M.
    Neurology; 1997 Sep; 49(3):739-45. PubMed ID: 9305334
    [Abstract] [Full Text] [Related]

  • 30. Hypomania induced by gabapentin.
    Short C, Cooke L.
    Br J Psychiatry; 1995 May; 166(5):679-80. PubMed ID: 7620760
    [No Abstract] [Full Text] [Related]

  • 31. Gabapentin--a new antiepileptic drug.
    Drug Ther Bull; 1994 Apr 21; 32(4):29-30. PubMed ID: 7635023
    [Abstract] [Full Text] [Related]

  • 32. Seizure frequency and CSF parameters in a double-blind placebo controlled trial of gabapentin in patients with intractable complex partial seizures.
    Ben-Menachem E, Söderfelt B, Hamberger A, Hedner T, Persson LI.
    Epilepsy Res; 1995 Jul 21; 21(3):231-6. PubMed ID: 8536677
    [Abstract] [Full Text] [Related]

  • 33. Gabapentin for treatment of epilepsy in children.
    Holmes GL.
    Semin Pediatr Neurol; 1997 Sep 21; 4(3):244-50. PubMed ID: 9323792
    [Abstract] [Full Text] [Related]

  • 34. Myoclonus associated with the use of gabapentin.
    Asconapé J, Diedrich A, DellaBadia J.
    Epilepsia; 2000 Apr 21; 41(4):479-81. PubMed ID: 10756416
    [Abstract] [Full Text] [Related]

  • 35. Cognitive abilities and adjustment with gabapentin: results of a multisite study.
    Dodrill CB, Arnett JL, Hayes AG, Garofalo EA, Greeley CA, Greiner MJ, Pierce MW.
    Epilepsy Res; 1999 Jun 21; 35(2):109-21. PubMed ID: 10372564
    [Abstract] [Full Text] [Related]

  • 36. [Gabapentin used in 559 patients with partial seizures. A multicenter observation study. Spanish Gabapentin Work Group].
    Herranz JL, Sol JM, Hernández G.
    Rev Neurol; 1999 Jun 21; 30(12):1141-5. PubMed ID: 10935239
    [Abstract] [Full Text] [Related]

  • 37. [Gabapentin in 50 patients with epilepsy].
    Gracia-Fleta F, Medrano-Martínez V, Castaño-Pérez MD, Hernández-Lorido R, Mañes R.
    Rev Neurol; 1999 Jun 21; 32(1):45-9. PubMed ID: 11293098
    [Abstract] [Full Text] [Related]

  • 38. Successful treatment of seizures and porphyria with gabapentin.
    Krauss GL, Simmons-O'Brien E, Campbell M.
    Neurology; 1995 Mar 21; 45(3 Pt 1):594-5. PubMed ID: 7898729
    [No Abstract] [Full Text] [Related]

  • 39. Gabapentin.
    Bruni J.
    Can J Neurol Sci; 1996 Nov 21; 23(4 Suppl 2):S10-2. PubMed ID: 8951214
    [Abstract] [Full Text] [Related]

  • 40. AUStralian study of titration to effect profile of safety (AUS-STEPS): high-dose gabapentin (neurontin) in partial seizures.
    Beran R, Berkovic S, Black A, Danta G, Dunne J, Frasca J, Grainger K, Kilpatrick C, McKenzie R, McLaughlin D, Schapel G, Somerville E.
    Epilepsia; 2001 Oct 21; 42(10):1335-9. PubMed ID: 11737169
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.